HALOZYME THERAPEUTICS, INC. (HALO) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$1.4B

Net Income/Loss (FY2025)

$316.9M

Total Assets (FY2025)

$2.5B

Total Equity (FY2025)

$48.8M

Cash Flows from Operating Activities (FY2025)

$651.6M

Source: HALOZYME THERAPEUTICS, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.